Showing results (1131-1140 of 1,231) with videos related to

Sort By:
Pageof 124
International Journal of Hematology|September 26, 2014
Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxabanTakumi Aota, Katsuki Naitoh, Hideo Wada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Therapeutic strategy for neuroendocrine tumor of the rectum]Shinobu Ohnuma, Takeshi Naitoh, Sho Haneda, et al.
Surgical Endoscopy|May 29, 2015
Surgeons have knowledge gaps in the safe use of energy devices: a multicenter cross-sectional studyYusuke Watanabe, Yo Kurashima, Amin Madani, et al.
International Journal of Clinical Oncology|May 8, 2014
Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effectsToshihiro Komura, Koh Miura, Tetsuhiko Shirasaka, et al.
Internal Medicine (Tokyo, Japan)|April 4, 2014
Histiocytic sarcoma of the bile ductKatsuyuki Miyabe, Ayako Masaki, Takahiro Nakazawa, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 29, 2021
Pancreatic cancer in patients with autoimmune pancreatitis: A scoping reviewPeter Macinga, Lukas Bajer, Marco Del Chiaro, et al.
Annals of Gastroenterological Surgery|September 4, 2023
Impact of laparoscopic surgery on short-term and long-term outcomes in elderly obese patients with colon cancerNobuaki Hoshino, Koya Hida, Yusuke Fujita, et al.
Asian Journal of Endoscopic Surgery|November 22, 2024
Usefulness of participation of endoscopic surgical skill qualification system-qualified surgeons in laparoscopic high anterior resectionNaruhiko Sawada, Shumpei Mukai, Tomonori Akagi, et al.
Asian Journal of Endoscopic Surgery|July 23, 2020
Current status of laparoscopic bariatric/metabolic surgery in Japan: The sixth nationwide survey by the Japan Consortium of Obesity and Metabolic SurgeryMasayuki Ohta, Kazunori Kasama, Akira Sasaki, et al.
Clinical Colorectal Cancer|February 27, 2017
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal CancerTakayuki Yoshino, Hiroyuki Uetake, Katsuya Tsuchihara, et al.
Pageof 124